Tufts Clinical and Translational Research Institute View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2013-2018

FUNDING AMOUNT

26360120 USD

ABSTRACT

Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4). More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9278321

Related SciGraph Publications

  • 2019-01-22. Prolonged duration of early antibiotic therapy in extremely premature infants in PEDIATRIC RESEARCH
  • 2019-01-14. Mindfulness is associated with psychological health and moderates the impact of fibromyalgia in CLINICAL RHEUMATOLOGY
  • 2019-01. The role of personality in patients with fibromyalgia in CLINICAL RHEUMATOLOGY
  • 2018-12. Hemodialysis patient characteristics associated with better experience as measured by the In-center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) survey in BMC NEPHROLOGY
  • 2018-12. Evaluation of non-response to the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) survey in BMC HEALTH SERVICES RESEARCH
  • 2018-12. CDK6 inhibits white to beige fat transition by suppressing RUNX1 in NATURE COMMUNICATIONS
  • 2018-12. Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages in FILARIA JOURNAL
  • 2018-08. The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis in JOURNAL OF URBAN HEALTH
  • 2018-05-18. Assessment of a shortened informed consent form for pediatric research: a pilot study in PEDIATRIC RESEARCH
  • 2018-05-02. Altered resting state functional connectivity of the cognitive control network in fibromyalgia and the modulation effect of mind-body intervention in BRAIN IMAGING AND BEHAVIOR
  • 2018-04. Going Beyond Frequency: A Qualitative Study to Explore New Dimensions for the Measurement of Family Meals in JOURNAL OF CHILD AND FAMILY STUDIES
  • 2017-12. Leveraging pediatric PROMIS item banks to assess physical functioning in children at risk for severe functional loss in JOURNAL OF PATIENT-REPORTED OUTCOMES
  • 2017-12. Improving heart health among Black/African American women using civic engagement: a pilot study in BMC PUBLIC HEALTH
  • 2017-12. Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions in BMC MUSCULOSKELETAL DISORDERS
  • 2017-12. Tufts PACE Clinical Predictive Model Registry: update 1990 through 2015 in DIAGNOSTIC AND PROGNOSTIC RESEARCH
  • 2017-11. Self-Inflicted Abdominal Stab Wounds Have a Higher Rate of Non-therapeutic Laparotomy/Laparoscopy and a Lower Risk of Injury in WORLD JOURNAL OF SURGERY
  • 2017-10. Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers in PHARMACEUTICAL RESEARCH
  • 2017-10. Effects of Tai Chi versus Physical Therapy on Mindfulness in Knee Osteoarthritis in MINDFULNESS
  • 2017-03. The Role of Community Education in Increasing Knowledge of Breast Health and Cancer: Findings from the Asian Breast Cancer Project in Boston, Massachusetts in JOURNAL OF CANCER EDUCATION
  • 2016-12. Physical examination findings and their relationship with performance-based function in adults with knee osteoarthritis in BMC MUSCULOSKELETAL DISORDERS
  • 2016-10. An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome in SCIENTIFIC REPORTS
  • 2016-08. Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy in DIGESTIVE DISEASES AND SCIENCES
  • 2016-05. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia in LEUKEMIA
  • 2016-04. Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico in LUNG
  • 2016-04. Where is the leak in the pipeline? Investigating gender differences in academic promotion at an academic medical centre in PERSPECTIVES ON MEDICAL EDUCATION
  • 2016-02. Effect of Probationary Accreditation on Recruitment of Psychiatry Residents in ACADEMIC PSYCHIATRY
  • 2015-12. Patient-Reported Outcomes Measurement Information System (PROMIS) instruments among individuals with symptomatic knee osteoarthritis: a cross-sectional study of floor/ceiling effects and construct validity in BMC MUSCULOSKELETAL DISORDERS
  • 2015-12. A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial in TRIALS
  • 2015-12. C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes in BMC CARDIOVASCULAR DISORDERS
  • 2015-10. Vascular complications in autosomal dominant polycystic kidney disease in NATURE REVIEWS NEPHROLOGY
  • 2015-01. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial in KIDNEY INTERNATIONAL
  • 2015-01. Controversies in Cardioembolic Stroke in CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE
  • 2014-12. Emergence and evolution of social self-management of Parkinson’s disease: study protocol for a 3-year prospective cohort study in BMC NEUROLOGY
  • 2014-12. Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial in BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
  • 2014-08. Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "26360120"
        }, 
        "description": "Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4).", 
        "endDate": "2018-09-30T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.429651.d", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2705244", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2705244"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "UL1TR001064"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "CTR home", 
          "T1-T4 spectrum", 
          "Tufts CTSl", 
          "Tufts hospitals", 
          "translational gap", 
          "collaborative CTR", 
          "novel methods;4", 
          "Brandeis University", 
          "translation", 
          "effective clinical practice", 
          "Section I", 
          "health impacts", 
          "biomedical sciences", 
          "RAND Corporation", 
          "bedside", 
          "widespread impact", 
          "Aim 2", 
          "T2", 
          "Tufts Clinical", 
          "translational research", 
          "institutionsjS", 
          "Instmctions", 
          "opportunity", 
          "TS-", 
          "strategically-", 
          "entire spectrum", 
          "way", 
          "health", 
          "Section III", 
          "aim", 
          "Tl", 
          "high-quality resources", 
          "Northeastern University", 
          "development", 
          "relevance", 
          "Translational Science Institute", 
          "services", 
          "tai^eted education", 
          "second CTSA", 
          "care delivery", 
          "public health", 
          "specific focus", 
          "Tufts CTSl building", 
          "partners", 
          "public need", 
          "spectmm", 
          "operationalize", 
          "pnsmise", 
          "Section II", 
          "full-spectrum translational research", 
          "Aim 1", 
          "special assets", 
          "bench", 
          "platform", 
          "financial management system", 
          "full spectrum", 
          "synergistic resources", 
          "community", 
          "committee", 
          "industry partners", 
          "health policy", 
          "other necessary structures", 
          "training", 
          "organization", 
          "field", 
          "Aim 4", 
          "central office personnel", 
          "CTR", 
          "innovative resources", 
          "Aim 3", 
          "Translational Research Institute", 
          "prior CTR resources", 
          "national leadership", 
          "TS", 
          "T1", 
          "CTR workforce", 
          "efficient access", 
          "education", 
          "T4", 
          "infra- stnjcture", 
          "educational programs", 
          "partners Include 12 Tufts University schools/research centers", 
          "promise", 
          "academic institutions", 
          "program", 
          "home", 
          "commitment", 
          "Section IV", 
          "application's four sections", 
          "CTSL", 
          "disciplines", 
          "clinical ahd", 
          "policy", 
          "sen/ices"
        ], 
        "name": "Tufts Clinical and Translational Research Institute", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.429997.8", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.429997.8", 
              "name": "TUFTS UNIVERSITY BOSTON", 
              "type": "Organization"
            }, 
            "familyName": "SELKER", 
            "givenName": "HARRY P.", 
            "id": "sg:person.01360626137.26", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01360626137.26", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2705244"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2021-01-20T02:59", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_21.xml.gz", 
        "startDate": "2013-09-26T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9278321"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2705244'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2705244'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2705244'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2705244'


     

    This table displays all metadata directly associated to this object as RDF triples.

    138 TRIPLES      19 PREDICATES      116 URIs      108 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2705244 schema:about anzsrc-for:2211
    2 schema:amount Na98a157a228640888155fc2e30c27388
    3 schema:description Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1) translation, crucial to having health impact, translation into effective clinical practice (T2), care delivery and public health (TS), and health policy ('T4). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (Tl) translation and crucially for having health impact, translation into effective clinical practice (T2), care delivery and public health (TS-), and health policy (?T4).
    4 schema:endDate 2018-09-30T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.429651.d
    6 schema:identifier N0f574647d91b48548b9f1bb6bf965039
    7 N9f1a9298362c4931a5d03d14cf989227
    8 schema:inLanguage en
    9 schema:keywords Aim 1
    10 Aim 2
    11 Aim 3
    12 Aim 4
    13 Brandeis University
    14 CTR
    15 CTR home
    16 CTR workforce
    17 CTSL
    18 Instmctions
    19 Northeastern University
    20 RAND Corporation
    21 Section I
    22 Section II
    23 Section III
    24 Section IV
    25 T1
    26 T1-T4 spectrum
    27 T2
    28 T4
    29 TS
    30 TS-
    31 Tl
    32 Translational Research Institute
    33 Translational Science Institute
    34 Tufts CTSl
    35 Tufts CTSl building
    36 Tufts Clinical
    37 Tufts hospitals
    38 academic institutions
    39 aim
    40 application's four sections
    41 bedside
    42 bench
    43 biomedical sciences
    44 care delivery
    45 central office personnel
    46 clinical ahd
    47 collaborative CTR
    48 commitment
    49 committee
    50 community
    51 development
    52 disciplines
    53 education
    54 educational programs
    55 effective clinical practice
    56 efficient access
    57 entire spectrum
    58 field
    59 financial management system
    60 full spectrum
    61 full-spectrum translational research
    62 health
    63 health impacts
    64 health policy
    65 high-quality resources
    66 home
    67 industry partners
    68 infra- stnjcture
    69 innovative resources
    70 institutionsjS
    71 national leadership
    72 novel methods;4
    73 operationalize
    74 opportunity
    75 organization
    76 other necessary structures
    77 partners
    78 partners Include 12 Tufts University schools/research centers
    79 platform
    80 pnsmise
    81 policy
    82 prior CTR resources
    83 program
    84 promise
    85 public health
    86 public need
    87 relevance
    88 second CTSA
    89 sen/ices
    90 services
    91 special assets
    92 specific focus
    93 spectmm
    94 strategically-
    95 synergistic resources
    96 tai^eted education
    97 training
    98 translation
    99 translational gap
    100 translational research
    101 way
    102 widespread impact
    103 schema:name Tufts Clinical and Translational Research Institute
    104 schema:recipient N7ec3406f36204e9aa56f608b2b06d699
    105 sg:person.01360626137.26
    106 https://www.grid.ac/institutes/grid.429997.8
    107 schema:sameAs https://app.dimensions.ai/details/grant/grant.2705244
    108 schema:sdDatePublished 2021-01-20T02:59
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher N6cfcd179b1c945e1a9a89149b172eb68
    111 schema:startDate 2013-09-26T00:00:00Z
    112 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9278321
    113 sgo:license sg:explorer/license/
    114 sgo:sdDataset grants
    115 rdf:type schema:MonetaryGrant
    116 N0f574647d91b48548b9f1bb6bf965039 schema:name nih_id
    117 schema:value UL1TR001064
    118 rdf:type schema:PropertyValue
    119 N6cfcd179b1c945e1a9a89149b172eb68 schema:name Springer Nature - SN SciGraph project
    120 rdf:type schema:Organization
    121 N7ec3406f36204e9aa56f608b2b06d699 schema:member sg:person.01360626137.26
    122 schema:roleName PI
    123 rdf:type schema:Role
    124 N9f1a9298362c4931a5d03d14cf989227 schema:name dimensions_id
    125 schema:value 2705244
    126 rdf:type schema:PropertyValue
    127 Na98a157a228640888155fc2e30c27388 schema:currency USD
    128 schema:value 26360120
    129 rdf:type schema:MonetaryAmount
    130 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    131 rdf:type schema:DefinedTerm
    132 sg:person.01360626137.26 schema:affiliation https://www.grid.ac/institutes/grid.429997.8
    133 schema:familyName SELKER
    134 schema:givenName HARRY P.
    135 rdf:type schema:Person
    136 https://www.grid.ac/institutes/grid.429651.d schema:Organization
    137 https://www.grid.ac/institutes/grid.429997.8 schema:name TUFTS UNIVERSITY BOSTON
    138 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...